Ellington Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Ellington Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,300	Closed	-$909K	–	85
2020 Q1	$909K	Buy	16,300 +1,200	+8%	+$73.3K	0.21%	127
2019 Q4	$969K	Buy	15,100 +8,900	+144%	+$510K	0.21%	90
2019 Q3	$314K	Sell	6,200 -2,400	-28%	-$113K	0.06%	352
2019 Q2	$390K	Sell	8,600 -500	-5%	-$23.3K	0.07%	296
2019 Q1	$434K	Buy	+9,100	New	+$453K	0.08%	263
2017 Q3	–	Sell	-5,300	Closed	-$295K	–	646
2017 Q2	$295K	Buy	+5,300	New	+$288K	0.04%	399
2017 Q1	–	Sell	-17,200	Closed	-$1M	–	696
2016 Q4	$1M	Buy	+17,200	New	+$940K	0.15%	71
2014 Q3	–	Sell	-12,500	Closed	-$606K	–	310
2014 Q2	$606K	Buy	+12,500	New	+$616K	0.28%	73

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ellington Management Group's BMY Position: Q2 2020 in Review

Ellington Management Group sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 16,300 shares — an estimated $909K sold.

Ellington Management Group first reported a position in BMY in Q2 2014 and held it in 8 quarters. The position peaked at $1M in Q4 2016. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Ellington Management Group reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 16,300 Bristol-Myers Squibb shares in Q2 2020, an estimated $909K.
Ellington Management Group first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 8 quarters.
Ellington Management Group's Bristol-Myers Squibb position peaked at $1M in Q4 2016.
2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.